Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04405297 · ClinicalTrials.gov registry record
A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells
A clinical trial, sponsored by Sanford Health.
- Terminated
- Registry status
- 14
- Enrollment target
NCT04405297: Clinical Trial study, sponsored by Sanford Health.
NCT04405297 is a clinical trial that was terminated before completion, run by Sanford Health. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04405297 was terminated before completion, sponsored by Sanford Health.
- TERMINATED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This is a prospective, multi-location safety and effectiveness study, and data registry of autologous adult ADRCs generated by the Transpose® RT System in subjects with OA in the shoulder, wrist, knee, hip, or ankle.
Primary Outcome
A one-sided binomial test will be used with a significance level of 0.05 to test whether safety was significantly lower than 20%. Each cohort will be analyzed independently.
Interventions
- DEVICE Adipose-derived regenerative cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-05-24 |
| Est. Completion | 2024-09-23 |
Why NCT04405297 stopped before completion
NCT04405297 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Adipose-derived regenerative cells is the first listed.
NCT04405297 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04405297 about?
NCT04405297 is a clinical study titled "A Disease-based Treatment Study for Diagnosed Osteoarthritis Utilizing Adipose-derived Regenerative Cells". This is a prospective, multi-location safety and effectiveness study, and data registry of autologous adult ADRCs generated by the Transpose® RT System in subjects with OA in the shoulder, wrist, knee, hip, or ankle.
What is the current status of trial NCT04405297?
This trial is currently terminated. The enrollment target is 14 participants. The study started on 2021-05-24. Estimated completion is 2024-09-23.
What interventions are being tested in trial NCT04405297?
The interventions under investigation include: Adipose-derived regenerative cells (DEVICE).
Who is sponsoring clinical trial NCT04405297?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy